NEUCA Past Earnings Performance
Past criteria checks 4/6
NEUCA has been growing earnings at an average annual rate of 3%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 8.7% per year. NEUCA's return on equity is 13.1%, and it has net margins of 1.3%.
Key information
3.0%
Earnings growth rate
2.4%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 8.7% |
| Return on equity | 13.1% |
| Net Margin | 1.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How NEUCA makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 12,343 | 161 | 1,149 | 0 |
| 30 Jun 24 | 12,125 | 165 | 1,117 | 0 |
| 31 Mar 24 | 11,973 | 155 | 1,072 | 0 |
| 31 Dec 23 | 11,813 | 146 | 1,056 | 0 |
| 30 Sep 23 | 11,813 | 128 | 1,018 | 0 |
| 30 Jun 23 | 11,654 | 108 | 991 | 0 |
| 31 Mar 23 | 11,418 | 125 | 932 | 0 |
| 31 Dec 22 | 11,232 | 137 | 892 | 0 |
| 30 Sep 22 | 10,962 | 148 | 877 | 0 |
| 30 Jun 22 | 10,705 | 163 | 831 | 0 |
| 31 Mar 22 | 10,381 | 161 | 813 | 0 |
| 31 Dec 21 | 9,864 | 151 | 777 | 0 |
| 30 Sep 21 | 9,575 | 144 | 731 | 0 |
| 30 Jun 21 | 9,329 | 149 | 714 | 0 |
| 31 Mar 21 | 8,907 | 142 | 681 | 0 |
| 31 Dec 20 | 9,245 | 142 | 683 | 0 |
| 30 Sep 20 | 8,996 | 148 | 674 | 0 |
| 30 Jun 20 | 8,695 | 131 | 657 | 0 |
| 31 Mar 20 | 8,772 | 130 | 681 | 0 |
| 31 Dec 19 | 8,272 | 117 | 650 | 0 |
| 30 Sep 19 | 8,079 | 116 | 630 | 0 |
| 30 Jun 19 | 7,941 | 113 | 633 | 0 |
| 31 Mar 19 | 7,731 | 100 | 628 | 0 |
| 31 Dec 18 | 7,753 | 95 | 636 | 0 |
| 30 Sep 18 | 7,700 | 103 | 632 | 0 |
| 30 Jun 18 | 7,643 | 99 | 625 | 0 |
| 31 Mar 18 | 7,645 | 95 | 611 | 0 |
| 31 Dec 17 | 7,485 | 94 | 598 | 0 |
| 30 Sep 17 | 7,433 | 91 | 590 | 0 |
| 30 Jun 17 | 7,321 | 97 | 582 | 0 |
| 31 Mar 17 | 7,217 | 107 | 570 | 0 |
| 31 Dec 16 | 7,077 | 112 | 552 | 0 |
| 30 Sep 16 | 6,946 | 108 | 551 | 0 |
| 30 Jun 16 | 6,897 | 105 | 540 | 0 |
| 31 Mar 16 | 6,920 | 105 | 538 | 0 |
| 31 Dec 15 | 6,946 | 101 | 539 | 0 |
| 30 Sep 15 | 7,011 | 113 | 536 | 0 |
| 30 Jun 15 | 7,100 | 100 | 536 | 0 |
| 31 Mar 15 | 6,957 | 89 | 525 | 0 |
| 31 Dec 14 | 6,569 | 93 | 498 | 0 |
| 30 Sep 14 | 6,199 | 72 | 472 | 0 |
| 30 Jun 14 | 5,897 | 80 | 445 | 0 |
| 31 Mar 14 | 5,759 | 89 | 428 | 0 |
| 31 Dec 13 | 5,795 | 85 | 431 | 0 |
Quality Earnings: 7HD has high quality earnings.
Growing Profit Margin: 7HD's current net profit margins (1.3%) are higher than last year (1.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7HD's earnings have grown by 3% per year over the past 5 years.
Accelerating Growth: 7HD's earnings growth over the past year (26.3%) exceeds its 5-year average (3% per year).
Earnings vs Industry: 7HD earnings growth over the past year (26.3%) did not outperform the Healthcare industry 40.5%.
Return on Equity
High ROE: 7HD's Return on Equity (13.1%) is considered low.